The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

KPTI FINANCIAL STATEMENTS

Karyopharm Therapeutics Inc — balance sheet, income statement and cash flow trends

KPTIKaryopharm Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue146.6 M $Gross Profit140.6 M $ · 96%Operating Income-82.4 M $ · -56%Pre-tax Income-224.8 M $ · -153%Net Income to Owners-224.7 M $ · -153%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue146.6 M $+6.8%
Gross Profit140.6 M $+6.3%
Operating Income-82.4 M $—
EBITDA-112.5 M $—
Net Income to Owners-224.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-250 M0250 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets111.3 M
  • Current Liabilities134.2 M $30%
  • Long-term Liabilities307.3 M $70%

Key Figures

YoY change
Total Assets111.3 M $+6.1%
Total Liabilities441.5 M $+28.4%
Total Equity-330.2 M $—
Cash & ST Investments65.1 M $+25.9%
Total Debt215.9 M $+13.3%
Net Debt160.9 M $+5.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M-25 M0-65.3 M $Operating3 M $Investing78.6 M $Financing16.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-65.3 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-65.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on KPTI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.